Setting out an ambitious strategy and ensuring it is implemented
The BIOASTER corporate governance consists of a Board of Directors and a Scientific Advisory Board.
Philippe Archinard – President
Board of directors
LYONBIOPÔLE
Philippe ARCHINARD
President
LYONBIOPÔLE
Florence AGOSTINO-ETCHETTO
INSTITUT PASTEUR
François ROMANEUX
BIOMÉRIEUX
François LACOSTE
BOEHRINGER
Erick LELOUCHE
CNRS
Frédéric FAURE
CEA
Olivier Peyret
DANONE
Gérard DENARIAZ
INSERM
Claire GIRY
INSTITUT MÉRIEUX
Jean-Luc BELINGARD
SANOFI PASTEUR
Marie-José QUENTIN-MILLET
UNIVERSITÉ de LYON
En cours de désignation
SME
Florence SEJOURNE
SANOFI
Jacques VOLCKMANN
Vincent THOMAS
Marie-Danièle CAMPION
Rectrice de l’Académie de Lyon
LE MONDE VÉTÉRINAIRE
Emmanuelle SOUBEYRAN
LA METROPOLE DE LYON
David KIMELFELD
RÉGION AUVERGNE RHÔNE-ALPES
Laurent WAUQUIEZ
MEDICEN
En cours de nomination
Scientific advisory board
The board meets twice a year on BIOASTER premises.
Dr. Didier MAZEL (Institut Pasteur, Paris, France) is the chariman of the board.
Pr. ANDREMONT Antoine
Laboratoire de bactériologie
Hôpital Bichat-Claude Bernard, Paris, France
Pr. D’ACREMONT Valérie
Researcher chez SwissTPH, Switzerland
Pr. de WILDE Michel
Board member, Infectious Disease Research Institute, Seattle, USA
Dr. HEILMAN Carole
National Institute of Allergy and Infectious Diseases (NIAID)& National Institutes of Health (NIH), USA
Dr. KIENY Marie-Paule
Adjoint director WHO & INSERM, Paris, France
Dr. LOCHT Camille
Institut Pasteur de Lille, France
Pr. MAINARDI Jean-Luc
Hôpitaux Universitaires Paris Ouest, France
Dr. MERCENIER Annick
NutriLead, Switzerland
Pr. PANTALEO Giuseppe
Centre hospitalier Universitaire Vaudois, Lausanne (CHUV), Switzerland
Pr. SOKOL Harry
Hôpital Saint-Antoine, Paris, France
Dr. VIARI Alain
INRIA, France